More Resources Sought For Using Patient-Preference Data In Device Reviews
This article was originally published in The Gray Sheet
Some device user fee revenue could be used to enhance application of patient-preference data, FDA said at a recent meeting of patient and consumer groups about user-fee reauthorization. Several groups urged greater emphasis in that area at the closed-door meeting, and some groups also pushed for increasing device user fees closer to the much higher levels charged to drug firms.
Register for our free email digests: